| Date | Title | Description |
| 20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital flowing into the industry.
While biotech VC investments in 2022 failed to live up to 2021's banner year, the second half still saw a steady st... |
| 16.05.2023 | Belgium-based Dualyx raises EUR 40 million in Series A | Zwijnaarde, Belgium-based biotechnology company which specializes in advancing immune modulators, Dualyx, raised EUR 40 million (USD 44 million) in Series A. The round took place on May 15, 2023. Fountain Healthcare Partners, Forbion and An... |
| 15.05.2023 | Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic | May 15, 2023 |
| 15.05.2023 | Forbion co-leads €40 million Series A in Dualyx | Naarden, The Netherlands and Munich, Germany, 15 May, 2023 – Forbion, a leading European life sciences venture capital firm, today announces that it has co-led the closing of €40 ($44) million Series A financing in Dualyx NV. Dualyx, a Ghen... |
| 15.05.2023 | Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases | Andera Partners co-leads a €40 million Series A financing of Dualyx NV, a Ghent, Belgium based biotech developing next generation immune modulators. Alongside Andera, Fountain Healthcare Partners and Forbion co-led the round, with support f... |
| 15.05.2023 |
Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic | Use of proceeds will enable the development of the Company’s lead autoimmune program DT-001, targeting TNFR2, as well as its pipeline of Treg candidates
Financing co-led by Fountain Healthcare Partners, Forbion and Andera Partners with sup... |
| 15.05.2023 | Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic | - |
| 15.05.2023 | Dualyx Raises €40M in Series A Funding | Dualyx, a Zwijnaarde, Belgium-based biotechnology company which specializes in advancing immune modulators, raised €40M in Series A funding.
The round was led by Andera, Fountain Healthcare Partners and Forbion with participation from exist... |
| - | Dualyx | “About | Dualyx” |
